CVSB 📈 Morgan Stanley Trust - - Overview
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US61774R6018 • Ultrashort Bond
CVSB: Fixed, Variable, Floating-Rate, Securities
The fund seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (including any borrowings for investment purposes) in a portfolio of investment grade, short-term fixed, variable and floating-rate securities. The fund is actively managed, not designed to track a benchmark, and therefore not constrained by the composition of a benchmark.
Additional Sources for CVSB ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CVSB ETF Overview
Market Cap in USD | 207m |
Category | Ultrashort Bond |
TER | 0.24% |
IPO / Inception | 2023-01-30 |
CVSB ETF Ratings
Growth 5y | 61.7% |
Fundamental | - |
Dividend | 38.6% |
Rel. Strength Industry | 185 |
Analysts | - |
Fair Price Momentum | 50.59 USD |
Fair Price DCF | - |
CVSB Dividends
Dividend Yield 12m | 4.73% |
Yield on Cost 5y | 5.29% |
Annual Growth 5y | -1.87% |
Payout Consistency | 100.0% |
CVSB Growth Ratios
Growth Correlation 3m | 96% |
Growth Correlation 12m | 99.9% |
Growth Correlation 5y | 100% |
CAGR 5y | 6.09% |
CAGR/Mean DD 5y | 99.56 |
Sharpe Ratio 12m | 0.91 |
Alpha | 1.11 |
Beta | 0.03 |
Volatility | 2.89% |
Current Volume | 15.4k |
Average Volume 20d | 14.9k |
What is the price of CVSB stocks?
As of December 27, 2024, the stock is trading at USD 50.67 with a total of 15,400 shares traded.
Over the past week, the price has changed by +0.21%, over one month by +0.44%, over three months by +1.22% and over the past year by +6.27%.
As of December 27, 2024, the stock is trading at USD 50.67 with a total of 15,400 shares traded.
Over the past week, the price has changed by +0.21%, over one month by +0.44%, over three months by +1.22% and over the past year by +6.27%.
Is Morgan Stanley Trust - a good stock to buy?
Yes. Based on ValueRay Analyses, Morgan Stanley Trust - (NYSE ARCA:CVSB) is currently (December 2024) a good stock to buy. It has a ValueRay Growth Rating of 61.69 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CVSB as of December 2024 is 50.59. This means that CVSB is currently overvalued and has a potential downside of -0.16%.
Yes. Based on ValueRay Analyses, Morgan Stanley Trust - (NYSE ARCA:CVSB) is currently (December 2024) a good stock to buy. It has a ValueRay Growth Rating of 61.69 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CVSB as of December 2024 is 50.59. This means that CVSB is currently overvalued and has a potential downside of -0.16%.
Is CVSB a buy, sell or hold?
Morgan Stanley Trust - has no consensus analysts rating.
Morgan Stanley Trust - has no consensus analysts rating.
What are the forecast for CVSB stock price target?
According to ValueRays Forecast Model, CVSB Morgan Stanley Trust - will be worth about 54.6 in December 2025. The stock is currently trading at 50.67. This means that the stock has a potential upside of +7.84%.
According to ValueRays Forecast Model, CVSB Morgan Stanley Trust - will be worth about 54.6 in December 2025. The stock is currently trading at 50.67. This means that the stock has a potential upside of +7.84%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 54.6 | 7.8% |